Related Experiment Video
Updated: Jul 29, 2026
13:56
Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
Published on: November 28, 2012
[Preventive effect of carnosine on cataract development].
1Department of Ophthalmology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China. yhongb@fmmu.edu.cn
Yan Ke Xue Bao = Eye Science
|December 14, 2006
Summary
Carnosine, a dipeptide, shows anti-aging properties and may prevent cataract development by protecting proteins and DNA. Further research into its mechanisms could lead to new cataract therapies.
Area of Science:
- Biochemistry
- Gerontology
- Ophthalmology
Context:
- Carnosine (beta-alanyl-L-histidine) is a naturally occurring dipeptide with demonstrated in vivo and in vitro anti-aging effects.
- Emerging research suggests carnosine's potential role in preventing cataract development.
- The precise molecular mechanisms underlying carnosine's anti-cataract effects require further elucidation.
Purpose:
- To explore the potential of carnosine in delaying cataract formation.
- To investigate the molecular mechanisms through which carnosine might exert its protective effects against cataracts.
Summary:
- Carnosine, a simple dipeptide, exhibits anti-aging properties.
- Studies indicate carnosine may prevent cataract development through mechanisms including anti-glycation, antioxidation, and protection against protein cross-linking and DNA damage.
- The molecular basis for carnosine's potential anti-cataract effects is under investigation.
Impact:
- Understanding carnosine's biological features and mechanisms in delaying cataractogenesis could pave the way for novel therapeutic strategies for cataract prevention.
- This research may offer new insights into age-related eye diseases and their management.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:23Catenins
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...